Bannasch P, Hacker H J, Tsuda H, Zerban H
Adv Enzyme Regul. 1986;25:279-96. doi: 10.1016/0065-2571(86)90019-1.
Systematic studies of the sequence of cellular changes during renal carcinogenesis induced in rats by stop experiments with N-nitrosomorpholine or streptozotocin and of human renal cell carcinomas led to the following main results and conclusions: All types of epithelial kidney tumors known from human pathology, namely clear-cell, acidophilic (granular), basophilic, chromophobic and oncocytic tumors, can be induced by the chemicals. Phenotypically altered epithelia resembling those in the tumors appear in single or multiple tubules long before unequivocal tumors develop. The progression from the preneoplastic tubular lesions to the tumors is an autogenous process which is independent of the further action of the carcinogen. At least three different types of tubular lesions can be distinguished: (a) Clear cell tubules storing glycogen in excess, (b) chromophobic or basophilic tubules frequently accumulating acid mucopolysaccharides (glycosaminoglycans, proteoglycans), and (c) oncocytic tubules accumulating atypical mitochondria. Whereas the precise site of origin of the clear cell tubules within the nephron remains unclear, the fine structural and cytochemical findings suggest that the chromophobic and basophilic tubules originate from the proximal and the oncocytic tubules from the distal nephron. Each type of tubular lesion is apparently the precursor of a cytologically specific tumor type. The well-known aberration in carbohydrate metabolism in renal tumors might occur in response to a carcinogen-induced metabolic derangement which is frequently associated with excessive storage of polysaccharides or lipids persisting for weeks and months until fast-growing tumors appear. Whereas the primary biochemical lesion leading to the persisting storage phenomena is most probably fixed at the genetic level, epigenetic changes, namely an adaptation of cellular enzymes gradually activating alternative metabolic pathways, might be responsible for the ultimate neoplastic transformation of the cell.
通过用N-亚硝基吗啉或链脲佐菌素进行终止实验诱导大鼠发生肾致癌作用以及对人类肾细胞癌进行系统研究,得出以下主要结果和结论:人类病理学中已知的所有类型的上皮性肾肿瘤,即透明细胞、嗜酸性(颗粒状)、嗜碱性、嫌色性和嗜酸性细胞瘤,均可由这些化学物质诱导产生。在明确的肿瘤形成之前很久,类似于肿瘤中的表型改变的上皮细胞就会出现在单个或多个肾小管中。从癌前肾小管病变发展为肿瘤是一个自发过程,与致癌物的进一步作用无关。至少可以区分出三种不同类型的肾小管病变:(a)储存过量糖原的透明细胞小管;(b)经常积累酸性粘多糖(糖胺聚糖、蛋白聚糖)的嫌色性或嗜碱性小管;(c)积累非典型线粒体的嗜酸性小管。虽然透明细胞小管在肾单位内的确切起源部位尚不清楚,但精细结构和细胞化学研究结果表明,嫌色性和嗜碱性小管起源于近端肾小管,而嗜酸性小管起源于远端肾单位。每种类型的肾小管病变显然是一种细胞学上特定肿瘤类型的前体。肾肿瘤中众所周知的碳水化合物代谢异常可能是由于致癌物诱导的代谢紊乱引起的,这种紊乱经常与多糖或脂质的过度储存有关,这种储存会持续数周和数月,直到快速生长的肿瘤出现。虽然导致持续储存现象的主要生化病变很可能在基因水平上固定下来,但表观遗传变化,即细胞酶的适应性变化逐渐激活替代代谢途径,可能是细胞最终发生肿瘤转化的原因。